POLD1 deficiency is involved in cognitive function impairment in AD patients and SAMP8 mice

In conclusion, this is the first study suggesting that the deficiency of POLD1 may aggravate AD progression, and POLD1 is a potential diagnostic marker and therapeutic target for AD.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research